Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Bold Types

Bay State biotech leaders blast Turing CEO

By , Globe Staff

If biotech industry leaders agree on anything, it’s that Turing Pharmaceuticals chief executive Martin Shkreli has made life difficult for all of them.

Trade pact offers shorter protection against copies of medications

By , Globe Staff

Initial reports suggested the sweeping deal won’t provide the 12 years of commercial protection the US-based biopharma industry had sought.

Dana-Farber asks court for joint inventor status patents

By , Globe Staff

The institute asked a federal court to name one of its scientists co-inventor on a series of cancer immunotherapy patents granted to a Japanese drug maker.

Price caps on drugs would quash innovation, Vertex CEO says

By , Globe Staff

Industry leaders warned that government efforts to rein in prescription drug prices could stymie the development of innovative medicines.